References
Aguilar-Gallardo, Cristóbal, Simón, & Carlos. (2013). Cells, Stem Cells, and Cancer Stem Cells. Seminars in Reproductive Medicine .
Ahmed, L. A., Rizk, S. M., & El-Maraghy, S. A. (2017). Pinocembrin ex vivo preconditioning improves the therapeutic efficacy of endothelial progenitor cells in monocrotaline-induced pulmonary hypertension in rats. Biochem Pharmacol, 138 , 193-204. doi:10.1016/j.bcp.2017.04.024
Alencar, A. K. N., Pimentel-Coelho, P. M., Montes, G. C., da Silva, M. M. C., Mendes, L. V. P., Montagnoli, T. L., . . . Zapata-Sudo, G. (2018). Human Mesenchymal Stem Cell Therapy Reverses Su5416/Hypoxia-Induced Pulmonary Arterial Hypertension in Mice.Front Pharmacol, 9 , 1395. doi:10.3389/fphar.2018.01395
Aliotta, J. M., Pereira, M., Wen, S., Dooner, M. S., Del Tatto, M., Papa, E., . . . Quesenberry, P. J. (2017). Bone Marrow Endothelial Progenitor Cells Are the Cellular Mediators of Pulmonary Hypertension in the Murine Monocrotaline Injury Model. Stem cells translational medicine, 6 (7), 1595-1606. doi:10.1002/sctm.16-0386
Aliotta, J. M., Pereira, M., Wen, S., Dooner, M. S., Del Tatto, M., Papa, E., . . . Klinger, J. R. (2016). Exosomes induce and reverse monocrotaline-induced pulmonary hypertension in mice.Cardiovascular research, 110 (3), 319-330. Retrieved fromhttps://pubmed.ncbi.nlm.nih.gov/26980205 . doi:10.1093/cvr/cvw054
Baber, S. R., Deng, W., Master, R. G., Bunnell, B. A., Taylor, B. K., Murthy, S. N., . . . Kadowitz, P. J. (2007). Intratracheal mesenchymal stem cell administration attenuates monocrotaline-induced pulmonary hypertension and endothelial dysfunction. Am J Physiol Heart Circ Physiol, 292 (2), H1120-1128. doi:10.1152/ajpheart.00173.2006
Baksh, D., Yao, R., & Tuan, R. S. (2007). Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem cells (Dayton, Ohio), 25 (6), 1384-1392. Retrieved fromhttps://pubmed.ncbi.nlm.nih.gov/17332507 .
Basile, D. P., & Yoder, M. C. (2014). Circulating and tissue resident endothelial progenitor cells. Journal of cellular physiology, 229 (1), 10-16. Retrieved fromhttps://pubmed.ncbi.nlm.nih.gov/23794280 . doi:10.1002/jcp.24423
Bayraktutan, U. (2019). Endothelial progenitor cells: Potential novel therapeutics for ischaemic stroke. Pharmacological research, 144 , 181-191. Retrieved from https://pubmed.ncbi.nlm.nih.gov/31004788 . doi:10.1016/j.phrs.2019.04.017
Bian, S., Zhang, L., Duan, L., Wang, X., Min, Y., & Yu, H. (2014). Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model.Journal of molecular medicine (Berlin, Germany), 92 (4), 387-397. Retrieved from https://pubmed.ncbi.nlm.nih.gov/24337504 . doi:10.1007/s00109-013-1110-5
Bianconi, V., Sahebkar, A., Kovanen, P., Bagaglia, F., Ricciuti, B., Calabro, P., . . . Pirro, M. (2018). Endothelial and cardiac progenitor cells for cardiovascular repair: A controversial paradigm in cell therapy. Pharmacol Ther, 181 , 156-168. Retrieved fromhttps://www.ncbi.nlm.nih.gov/pubmed/28827151 . doi:10.1016/j.pharmthera.2017.08.004
Brown, R. E., & McGuire, M. F. (2012). Oncogenesis recapitulates embryogenesis via the hypoxia pathway: morphoproteomics and biomedical analytics provide proof of concept and therapeutic options. Annals of clinical and laboratory science, 42 (3), 243-257. Retrieved fromhttps://pubmed.ncbi.nlm.nih.gov/22964612 .
Bull, T. M., Clark, B., McFann, K., & Moss, M. (2010). Pulmonary vascular dysfunction is associated with poor outcomes in patients with acute lung injury. American journal of respiratory and critical care medicine, 182 (9), 1123-1128. Retrieved fromhttps://pubmed.ncbi.nlm.nih.gov/20558628 . doi:10.1164/rccm.201002-0250OC
Cao, G., Liu, C., Wan, Z., Liu, K., Sun, H., Sun, X., . . . Zhang, X. (2015). Combined hypoxia inducible factor-1α and homogeneous endothelial progenitor cell therapy attenuates shunt flow-induced pulmonary arterial hypertension in rabbits. J Thorac Cardiovasc Surg, 150 (3), 621-632. doi:10.1016/j.jtcvs.2015.05.035
Chen, H., Yang, H., Yue, H., Strappe, P. M., Xia, P., Pan, L., . . . Wang, L. (2017). Mesenchymal Stem Cells Expressing eNOS and a Cav1 Mutant Inhibit Vascular Smooth Muscle Cell Proliferation in a Rat Model of Pulmonary Hypertension. Heart, lung & circulation, 26 (5), 509-518. Retrieved from https://pubmed.ncbi.nlm.nih.gov/27771236 . doi:10.1016/j.hlc.2016.08.002
Chen, J. Y., An, R., Liu, Z. J., Wang, J. J., Chen, S. Z., Hong, M. M., . . . Chen, Y. F. (2014). Therapeutic effects of mesenchymal stem cell-derived microvesicles on pulmonary arterial hypertension in rats.Acta Pharmacol Sin, 35 (9), 1121-1128. doi:10.1038/aps.2014.61
Cheng, G., Wang, X., Li, Y., & He, L. (2017). Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling. Stem cell research & therapy, 8 (1), 34. Retrieved fromhttps://pubmed.ncbi.nlm.nih.gov/28187784 . doi:10.1186/s13287-017-0480-y
de Mendonça, L., Felix, N. S., Blanco, N. G., Da Silva, J. S., Ferreira, T. P., Abreu, S. C., . . . Silva, P. L. (2017). Mesenchymal stromal cell therapy reduces lung inflammation and vascular remodeling and improves hemodynamics in experimental pulmonary arterial hypertension. Stem cell research & therapy, 8 (1), 220. doi:10.1186/s13287-017-0669-0
Deregibus, M. C., Cantaluppi, V., Calogero, R., Lo Iacono, M., Tetta, C., Biancone, L., . . . Camussi, G. (2007). Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood, 110 (7), 2440-2448. Retrieved from https://pubmed.ncbi.nlm.nih.gov/17536014 .
Diller, G. P., van Eijl, S., Okonko, D. O., Howard, L. S., Ali, O., Thum, T., . . . Wharton, J. (2008). Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension. Circulation, 117 (23), 3020-3030. doi:10.1161/circulationaha.108.769646
Duong, H. T., Comhair, S. A., Aldred, M. A., Mavrakis, L., Savasky, B. M., Erzurum, S. C., & Asosingh, K. (2011). Pulmonary artery endothelium resident endothelial colony-forming cells in pulmonary arterial hypertension. Pulm Circ, 1 (4), 475-486. doi:10.4103/2045-8932.93547
Ferkowicz, M. J., & Yoder, M. C. (2005). Blood island formation: longstanding observations and modern interpretations. Exp Hematol, 33 (9), 1041-1047. doi:10.1016/j.exphem.2005.06.006
Foris, V., Kovacs, G., Marsh, L. M., Bálint, Z., Tötsch, M., Avian, A., . . . Olschewski, H. (2016). CD133+ cells in pulmonary arterial hypertension. Eur Respir J, 48 (2), 459-469. doi:10.1183/13993003.01523-2015
Fraser, J. K., Wulur, I., Alfonso, Z., & Hedrick, M. H. (2006). Fat tissue: an underappreciated source of stem cells for biotechnology.Trends in biotechnology, 24 (4), 150-154. Retrieved fromhttps://pubmed.ncbi.nlm.nih.gov/16488036 .
Fukumitsu, M., & Suzuki, K. (2019). Mesenchymal stem/stromal cell therapy for pulmonary arterial hypertension: Comprehensive review of preclinical studies. Journal of cardiology, 74 (4), 304-312. Retrieved from https://pubmed.ncbi.nlm.nih.gov/31109735 . doi:10.1016/j.jjcc.2019.04.006
García-Lucio, J., Tura-Ceide, O., Del Pozo, R., Blanco, I., Pizarro, S., Ferrer, E., . . . Barberà, J. A. (2017). Effect of targeted therapy on circulating progenitor cells in precapillary pulmonary hypertension.International journal of cardiology, 228 , 238-243. doi:10.1016/j.ijcard.2016.11.175
Gazdic, M., Volarevic, V., Harrell, C. R., Fellabaum, C., Jovicic, N., Arsenijevic, N., & Stojkovic, M. (2018). Stem Cells Therapy for Spinal Cord Injury. Int J Mol Sci, 19 (4). doi:10.3390/ijms19041039
Golpanian, S., DiFede, D. L., Khan, A., Schulman, I. H., Landin, A. M., Tompkins, B. A., . . . Hare, J. M. (2017). Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty. J Gerontol A Biol Sci Med Sci, 72 (11), 1505-1512. doi:10.1093/gerona/glx056
Granton, J., Langleben, D., Kutryk, M. B., Camack, N., Galipeau, J., Courtman, D. W., & Stewart, D. J. (2015). Endothelial NO-Synthase Gene-Enhanced Progenitor Cell Therapy for Pulmonary Arterial Hypertension: The PHACeT Trial. Circ Res, 117 (7), 645-654. doi:10.1161/circresaha.114.305951
Guber, S., Ebrahimian, T., Heidari, M., Eliopoulos, N., & Lehoux, S. (2018). Endothelial nitric oxide synthase overexpressing human early outgrowth cells inhibit coronary artery smooth muscle cell migration through paracrine functions. Scientific reports, 8 (1), 877. Retrieved from https://pubmed.ncbi.nlm.nih.gov/29343714 . doi:10.1038/s41598-017-18848-z
Hansmann, G., Plouffe, B. D., Hatch, A., von Gise, A., Sallmon, H., Zamanian, R. T., & Murthy, S. K. (2011). Design and validation of an endothelial progenitor cell capture chip and its application in patients with pulmonary arterial hypertension. Journal of molecular medicine (Berlin, Germany), 89 (10), 971-983. Retrieved fromhttps://pubmed.ncbi.nlm.nih.gov/21735044 . doi:10.1007/s00109-011-0779-6
Harper, R. L., Maiolo, S., Ward, R. J., Seyfang, J., Cockshell, M. P., Bonder, C. S., & Reynolds, P. N. (2019). BMPR2-expressing bone marrow-derived endothelial-like progenitor cells alleviate pulmonary arterial hypertension in vivo. Respirology, 24 (11), 1095-1103. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/30977250 . doi:10.1111/resp.13552
Hass, R., Kasper, C., Böhm, S., & Jacobs, R. (2011). Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell communication and signaling : CCS, 9 , 12. Retrieved fromhttps://pubmed.ncbi.nlm.nih.gov/21569606 . doi:10.1186/1478-811X-9-12
Heo, J. S., Choi, Y., Kim, H. S., & Kim, H. O. (2016). Comparison of molecular profiles of human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue. Int J Mol Med, 37 (1), 115-125. doi:10.3892/ijmm.2015.2413
Hu, S., Park, J., Liu, A., Lee, J., Zhang, X., Hao, Q., & Lee, J.-W. (2018). Mesenchymal Stem Cell Microvesicles Restore Protein Permeability Across Primary Cultures of Injured Human Lung Microvascular Endothelial Cells. Stem cells translational medicine, 7 (8), 615-624. Retrieved from https://pubmed.ncbi.nlm.nih.gov/29737632 . doi:10.1002/sctm.17-0278
Huang, J., Lu, W., Ouyang, H., Chen, Y., Zhang, C., Luo, X., . . . Wang, J. (2020). Transplantation of Mesenchymal Stem Cells Attenuates Pulmonary Hypertension by Normalizing the Endothelial-to-Mesenchymal Transition. Am J Respir Cell Mol Biol, 62 (1), 49-60. doi:10.1165/rcmb.2018-0165OC
Huang, W. C., Ke, M. W., Cheng, C. C., Chiou, S. H., Wann, S. R., Shu, C. W., . . . Liu, C. P. (2016). Therapeutic Benefits of Induced Pluripotent Stem Cells in Monocrotaline-Induced Pulmonary Arterial Hypertension. PLoS One, 11 (2), e0142476. doi:10.1371/journal.pone.0142476
Ichida, J. K., Blanchard, J., Lam, K., Son, E. Y., Chung, J. E., Egli, D., . . . Eggan, K. (2009). A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog. Cell Stem Cell, 5 (5), 491-503. doi:10.1016/j.stem.2009.09.012
Ingram, D. A., Mead, L. E., Tanaka, H., Meade, V., Fenoglio, A., Mortell, K., . . . Yoder, M. C. (2004). Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood, 104 (9), 2752-2760. Retrieved fromhttps://pubmed.ncbi.nlm.nih.gov/15226175 .
Junhui, Z., Xingxiang, W., Guosheng, F., Yunpeng, S., Furong, Z., & Junzhu, C. (2008). Reduced number and activity of circulating endothelial progenitor cells in patients with idiopathic pulmonary arterial hypertension. Respir Med, 102 (7), 1073-1079. doi:10.1016/j.rmed.2007.12.030
Lee, C., Mitsialis, S. A., Aslam, M., Vitali, S. H., Vergadi, E., Konstantinou, G., . . . Kourembanas, S. (2012). Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension. Circulation, 126 (22), 2601-2611. doi:10.1161/circulationaha.112.114173
Li, R., Lin, Q. X., Liang, X. Z., Liu, G. B., Tang, H., Wang, Y., . . . Peng, J. (2018). Stem cell therapy for treating osteonecrosis of the femoral head: From clinical applications to related basic research.Stem cell research & therapy, 9 (1), 291. doi:10.1186/s13287-018-1018-7
Li, X., Chen, C., Wei, L., Li, Q., Niu, X., Xu, Y., . . . Zhao, J. (2016). Exosomes derived from endothelial progenitor cells attenuate vascular repair and accelerate reendothelialization by enhancing endothelial function. Cytotherapy, 18 (2), 253-262. Retrieved fromhttps://pubmed.ncbi.nlm.nih.gov/26794715 . doi:10.1016/j.jcyt.2015.11.009
Liang, O. D., So, E. Y., Egan, P. C., Goldberg, L. R., Aliotta, J. M., Wu, K. Q., . . . Klinger, J. R. (2017). Endothelial to haematopoietic transition contributes to pulmonary arterial hypertension.Cardiovascular research, 113 (13), 1560-1573. doi:10.1093/cvr/cvx161
Liu, A., Zhang, X., He, H., Zhou, L., Naito, Y., Sugita, S., & Lee, J.-W. (2020). Therapeutic potential of mesenchymal stem/stromal cell-derived secretome and vesicles for lung injury and disease.Expert opinion on biological therapy, 20 (2), 125-140. Retrieved from https://pubmed.ncbi.nlm.nih.gov/31701782 . doi:10.1080/14712598.2020.1689954
Liu, B., Li, T., Peng, J. J., Zhang, J. J., Liu, W. Q., Luo, X. J., . . . Peng, J. (2016). Non-muscle myosin light chain promotes endothelial progenitor cells senescence and dysfunction in pulmonary hypertensive rats through up-regulation of NADPH oxidase. Eur J Pharmacol, 775 , 67-77. doi:10.1016/j.ejphar.2016.02.022
Liu, J., Li, P., Zhu, J., Lin, F., Zhou, J., Feng, B., . . . Cao, H. (2021). Mesenchymal stem cell-mediated immunomodulation of recruited mononuclear phagocytes during acute lung injury: a high-dimensional analysis study. Theranostics, 11 (5), 2232-2246. Retrieved fromhttps://pubmed.ncbi.nlm.nih.gov/33500722 . doi:10.7150/thno.52514
Liu, P., Zhang, H., Liu, J., Sheng, C., Zhang, L., & Zeng, Y. (2016). Changes of Number and Function of Late Endothelial Progenitor Cells in Peripheral Blood of COPD Patients Combined with Pulmonary Hypertension.The Thoracic and cardiovascular surgeon, 64 (4), 323-329. Retrieved from https://pubmed.ncbi.nlm.nih.gov/25226359 . doi:10.1055/s-0034-1389261
Liu, S., Hou, X., Chen, L., Hu, H., Sun, Q., Zhao, F., & Liu, C. (2018). Enhancing amplification of late-outgrowth endothelial cells by bilobalide. Journal of cellular and molecular medicine, 22 (7), 3340-3352. Retrieved fromhttps://pubmed.ncbi.nlm.nih.gov/29566307 . doi:10.1111/jcmm.13609
Liu, Y., Zhao, X., Ding, J., Xing, Y., Zhou, M., Wang, X., . . . Yang, J. (2020). Evidence of Accumulated Endothelial Progenitor Cells in the Lungs of Rats with Pulmonary Arterial Hypertension by (89)Zr-oxine PET Imaging. Mol Ther Methods Clin Dev, 17 , 1108-1117. doi:10.1016/j.omtm.2020.04.021
Loisel, F., Provost, B., Guihaire, J., Boulate, D., Arouche, N., Amsallem, M., . . . Mercier, O. (2019). Autologous endothelial progenitor cell therapy improves right ventricular function in a model of chronic thromboembolic pulmonary hypertension. J Thorac Cardiovasc Surg, 157 (2), 655-666.e657. doi:10.1016/j.jtcvs.2018.08.083
Lopatina, T., Bruno, S., Tetta, C., Kalinina, N., Porta, M., & Camussi, G. (2014). Platelet-derived growth factor regulates the secretion of extracellular vesicles by adipose mesenchymal stem cells and enhances their angiogenic potential. Cell communication and signaling : CCS, 12 , 26. Retrieved fromhttps://pubmed.ncbi.nlm.nih.gov/24725987 . doi:10.1186/1478-811X-12-26
Luo, M., Ling, T., Xie, W., Sun, H., Zhou, Y., Zhu, Q., . . . Grummt, I. (2013). NuRD blocks reprogramming of mouse somatic cells into pluripotent stem cells. Stem cells (Dayton, Ohio), 31 (7), 1278-1286. doi:10.1002/stem.1374
Lyon, L. (2018). Stem cell therapies in neurology: the good, the bad and the unknown. Brain, 141 (10), e77. doi:10.1093/brain/awy221
Malard, F., & Mohty, M. (2014). New insight for the diagnosis of gastrointestinal acute graft-versus-host disease. Mediators Inflamm, 2014 , 701013. doi:10.1155/2014/701013
Mandras, S. A., Mehta, H. S., & Vaidya, A. (2020). Pulmonary Hypertension: A Brief Guide for Clinicians. Mayo Clin Proc, 95 (9), 1978-1988. Retrieved fromhttps://www.ncbi.nlm.nih.gov/pubmed/32861339 . doi:10.1016/j.mayocp.2020.04.039
Marión, R. M., Strati, K., Li, H., Murga, M., Blanco, R., Ortega, S., . . . Blasco, M. A. (2009). A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature, 460 (7259), 1149-1153. doi:10.1038/nature08287
Medina, R. J., O’Neill, C. L., Sweeney, M., Guduric-Fuchs, J., Gardiner, T. A., Simpson, D. A., & Stitt, A. W. (2010). Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities. BMC medical genomics, 3 , 18. Retrieved from https://pubmed.ncbi.nlm.nih.gov/20465783 . doi:10.1186/1755-8794-3-18
Memon, B., & Abdelalim, E. M. (2020). Stem Cell Therapy for Diabetes: Beta Cells versus Pancreatic Progenitors. Cells, 9 (2). doi:10.3390/cells9020283
Minami, Y., Nakajima, T., Ikutomi, M., Morita, T., Komuro, I., Sata, M., & Sahara, M. (2015). Angiogenic potential of early and late outgrowth endothelial progenitor cells is dependent on the time of emergence.International journal of cardiology, 186 , 305-314. Retrieved fromhttps://pubmed.ncbi.nlm.nih.gov/25838182 . doi:10.1016/j.ijcard.2015.03.166
Mitalipov, S., & Wolf, D. (2009). Totipotency, pluripotency and nuclear reprogramming. Advances in biochemical engineering/biotechnology, 114 , 185-199. Retrieved fromhttps://pubmed.ncbi.nlm.nih.gov/19343304 . doi:10.1007/10_2008_45
Moradi, S., Braun, T., & Baharvand, H. (2018). miR-302b-3p Promotes Self-Renewal Properties in Leukemia Inhibitory Factor-Withdrawn Embryonic Stem Cells. Cell J, 20 (1), 61-72. doi:10.22074/cellj.2018.4846
Moradi, S., Sharifi-Zarchi, A., Ahmadi, A., Mollamohammadi, S., Stubenvoll, A., Günther, S., . . . Baharvand, H. (2017). Small RNA Sequencing Reveals Dlk1-Dio3 Locus-Embedded MicroRNAs as Major Drivers of Ground-State Pluripotency. Stem Cell Reports, 9 (6), 2081-2096. doi:10.1016/j.stemcr.2017.10.009
Murohara, T. (2010). Cord blood-derived early outgrowth endothelial progenitor cells. Microvascular research, 79 (3), 174-177. Retrieved from https://pubmed.ncbi.nlm.nih.gov/20085776 . doi:10.1016/j.mvr.2010.01.008
Okita, K., Nakagawa, M., Hyenjong, H., Ichisaka, T., & Yamanaka, S. (2008). Generation of mouse induced pluripotent stem cells without viral vectors. Science (New York, N.Y.), 322 (5903), 949-953. doi:10.1126/science.1164270
Ong, J. F., Ankrum, J. A., Dastidar, R. G., Levy, O., & Karp, J. M. (2014). Enhanced mesenchymal stem cell immunomodulatory potency through intracellular budesonide microparticles. British Journal of Surgery, 2014 May (101), 36.
Ormiston, M. L., Deng, Y., Stewart, D. J., & Courtman, D. W. (2010). Innate immunity in the therapeutic actions of endothelial progenitor cells in pulmonary hypertension. Am J Respir Cell Mol Biol, 43 (5), 546-554. doi:10.1165/rcmb.2009-0152OC
Paneni, F., Costantino, S., Kränkel, N., Cosentino, F., & Lüscher, T. F. (2016). Reprogramming ageing and longevity genes restores paracrine angiogenic properties of early outgrowth cells. European heart journal, 37 (22), 1733-1737. Retrieved fromhttps://pubmed.ncbi.nlm.nih.gov/26941203 . doi:10.1093/eurheartj/ehw073
Pelosi, E., Castelli, G., & Testa, U. (2014). Endothelial progenitors.Blood Cells Mol Dis, 52 (4), 186-194. doi:10.1016/j.bcmd.2013.11.004
Peng, L., Jia, Z., Yin, X., Zhang, X., Liu, Y., Chen, P., . . . Zhou, C. (2008). Comparative analysis of mesenchymal stem cells from bone marrow, cartilage, and adipose tissue. Stem cells and development, 17 (4), 761-773. Retrieved from https://pubmed.ncbi.nlm.nih.gov/18393634 . doi:10.1089/scd.2007.0217
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., . . . Marshak, D. R. (1999). Multilineage potential of adult human mesenchymal stem cells. Science (New York, N.Y.), 284 (5411), 143-147. Retrieved fromhttps://pubmed.ncbi.nlm.nih.gov/10102814 .
Pizarro, S., García-Lucio, J., Peinado, V. I., Tura-Ceide, O., Díez, M., Blanco, I., . . . Barberà, J. A. (2014). Circulating progenitor cells and vascular dysfunction in chronic obstructive pulmonary disease.PLoS One, 9 (8), e106163. doi:10.1371/journal.pone.0106163
Prater, D. N., Case, J., Ingram, D. A., & Yoder, M. C. (2007). Working hypothesis to redefine endothelial progenitor cells. Leukemia, 21 (6), 1141-1149. Retrieved fromhttps://pubmed.ncbi.nlm.nih.gov/17392816 .
Prokopi, M., & Mayr, M. (2011). Proteomics: a reality-check for putative stem cells. Circ Res, 108 (4), 499-511. Retrieved fromhttps://www.ncbi.nlm.nih.gov/pubmed/21335432 . doi:10.1161/CIRCRESAHA.110.226902
Rathinasabapathy, A., Bruce, E., Espejo, A., Horowitz, A., Sudhan, D. R., Nair, A., . . . Katovich, M. J. (2016). Therapeutic potential of adipose stem cell-derived conditioned medium against pulmonary hypertension and lung fibrosis. British journal of pharmacology, 173 (19), 2859-2879. Retrieved fromhttps://pubmed.ncbi.nlm.nih.gov/27448286 . doi:10.1111/bph.13562
Richardson, M. R., & Yoder, M. C. (2011). Endothelial progenitor cells: quo vadis? J Mol Cell Cardiol, 50 (2), 266-272. Retrieved fromhttps://www.ncbi.nlm.nih.gov/pubmed/20673769 . doi:10.1016/j.yjmcc.2010.07.009
Richmond, E. M. (1992). Early histological and ultrastructural changes in medullary fracture callusBrighton CT, Hunt RM. J Bone Joint Surg [Am]73:832, 1991. Journal of Oral & Maxillofacial Surgery, 50 (10), 1138.
Sa, S., Gu, M., Chappell, J., Shao, N. Y., Ameen, M., Elliott, K. A., . . . Rabinovitch, M. (2017). Induced Pluripotent Stem Cell Model of Pulmonary Arterial Hypertension Reveals Novel Gene Expression and Patient Specificity. Am J Respir Crit Care Med, 195 (7), 930-941. doi:10.1164/rccm.201606-1200OC
Schermuly, R. T., Ghofrani, H. A., Wilkins, M. R., & Grimminger, F. (2011). Mechanisms of disease: pulmonary arterial hypertension.Nat Rev Cardiol, 8 (8), 443-455. Retrieved fromhttps://www.ncbi.nlm.nih.gov/pubmed/21691314 . doi:10.1038/nrcardio.2011.87
Schniedermann, J., Rennecke, M., Buttler, K., Richter, G., Städtler, A.-M., Norgall, S., . . . Weich, H. A. (2010). Mouse lung contains endothelial progenitors with high capacity to form blood and lymphatic vessels. BMC cell biology, 11 , 50. Retrieved fromhttps://pubmed.ncbi.nlm.nih.gov/20594323 . doi:10.1186/1471-2121-11-50
Selvaraj, V., Plane, J. M., Williams, A. J., & Deng, W. (2010). Switching cell fate: the remarkable rise of induced pluripotent stem cells and lineage reprogramming technologies. Trends in biotechnology, 28 (4), 214-223. doi:10.1016/j.tibtech.2010.01.002
Shi, Y.-Y., Nacamuli, R. P., Salim, A., & Longaker, M. T. (2005). The osteogenic potential of adipose-derived mesenchymal cells is maintained with aging. Plastic and reconstructive surgery, 116 (6), 1686-1696. Retrieved fromhttps://pubmed.ncbi.nlm.nih.gov/16267433 .
Shi, Y. Y., Nacamuli, R. P., Salim, A., & Longaker, M. T. (2005). The osteogenic potential of adipose-derived mesenchymal cells is maintained with aging. Plastic and reconstructive surgery, 116 (6), 1686-1696. doi:10.1097/01.prs.0000185606.03222.a9
Southgate, L., Machado, R. D., Graf, S., & Morrell, N. W. (2020). Molecular genetic framework underlying pulmonary arterial hypertension.Nat Rev Cardiol, 17 (2), 85-95. Retrieved fromhttps://www.ncbi.nlm.nih.gov/pubmed/31406341 . doi:10.1038/s41569-019-0242-x
Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G., & Hochedlinger, K. (2008). Induced pluripotent stem cells generated without viral integration. Science (New York, N.Y.), 322 (5903), 945-949. doi:10.1126/science.1162494
Sun, C. K., Lin, Y. C., Yuen, C. M., Chua, S., Chang, L. T., Sheu, J. J., . . . Yip, H. K. (2012). Enhanced protection against pulmonary hypertension with sildenafil and endothelial progenitor cell in rats.International journal of cardiology, 162 (1), 45-58. doi:10.1016/j.ijcard.2011.05.002
Sun, H. X., Li, G. J., Du, Z. H., Bing, Z., Ji, Z. X., Luo, G., & Pan, S. L. (2019). The relationship between endothelial progenitor cells and pulmonary arterial hypertension in children with congenital heart disease. BMC Pediatr, 19 (1), 502. doi:10.1186/s12887-019-1884-x
Suzuki, T., Sato, Y., Yamamoto, H., Kato, T., Kitase, Y., Ueda, K., . . . Hayakawa, M. (2020). Mesenchymal stem/stromal cells stably transduced with an inhibitor of CC chemokine ligand 2 ameliorate bronchopulmonary dysplasia and pulmonary hypertension. Cytotherapy, 22 (4), 180-192. doi:10.1016/j.jcyt.2020.01.009
Takahashi, K., & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126 (4), 663-676. Retrieved fromhttps://pubmed.ncbi.nlm.nih.gov/16904174 .
Tonk, C. H., Witzler, M., Schulze, M., & Tobia Sc H, E. (2020).Mesenchymal Stem Cells : Essential Current Concepts in Stem Cell Biology.
Toshner, M., Voswinckel, R., Southwood, M., Al-Lamki, R., Howard, L. S., Marchesan, D., . . . Morrell, N. W. (2009). Evidence of dysfunction of endothelial progenitors in pulmonary arterial hypertension. Am J Respir Crit Care Med, 180 (8), 780-787. Retrieved fromhttps://www.ncbi.nlm.nih.gov/pubmed/19628780 . doi:10.1164/rccm.200810-1662OC
Ulloa-Montoya, F., Verfaillie, C. M., & Hu, W.-S. (2005). Culture systems for pluripotent stem cells. Journal of bioscience and bioengineering, 100 (1), 12-27. Retrieved fromhttps://pubmed.ncbi.nlm.nih.gov/16233846 .
Van Harmelen, V., Röhrig, K., & Hauner, H. (2004). Comparison of proliferation and differentiation capacity of human adipocyte precursor cells from the omental and subcutaneous adipose tissue depot of obese subjects. Metabolism: clinical and experimental, 53 (5), 632-637. Retrieved from https://pubmed.ncbi.nlm.nih.gov/15131769 .
Wang, E. L., Jia, M. M., Luo, F. M., Li, T., Peng, J. J., Luo, X. J., . . . Liu, B. (2019). Coordination between NADPH oxidase and vascular peroxidase 1 promotes dysfunctions of endothelial progenitor cells in hypoxia-induced pulmonary hypertensive rats. Eur J Pharmacol, 857 , 172459. doi:10.1016/j.ejphar.2019.172459
Wang, X. X., Zhang, F. R., Shang, Y. P., Zhu, J. H., Xie, X. D., Tao, Q. M., . . . Chen, J. Z. (2007). Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: a pilot randomized controlled trial. J Am Coll Cardiol, 49 (14), 1566-1571. doi:10.1016/j.jacc.2006.12.037
Wei, L., Zhu, W., Xia, L., Yang, Y., Liu, H., Shen, J., . . . Wang, C. (2013). Therapeutic effect of eNOS-transfected endothelial progenitor cells on hemodynamic pulmonary arterial hypertension. Hypertension research : official journal of the Japanese Society of Hypertension, 36 (5), 414-421. Retrieved fromhttps://pubmed.ncbi.nlm.nih.gov/23446773 . doi:10.1038/hr.2012.217
Weiss, M. L., Medicetty, S., Bledsoe, A. R., Rachakatla, R. S., Choi, M., Merchav, S., . . . Troyer, D. (2006). Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson’s disease. Stem cells (Dayton, Ohio), 24 (3), 781-792. Retrieved fromhttps://pubmed.ncbi.nlm.nih.gov/16223852 .
Woltjen, K., Michael, I. P., Mohseni, P., Desai, R., Mileikovsky, M., Hämäläinen, R., . . . Nagy, A. (2009). piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature, 458 (7239), 766-770. doi:10.1038/nature07863
Xia, L., Zhu, J. H., Qiu, F. Y., Yang, Y., Xie, X. D., Wang, X. X., . . . Fu, G. S. (2009). Senescent endothelial progenitor cells from dogs with pulmonary arterial hypertension: a before-after self-controlled study. J Physiol Sci, 59 (6), 429-437. doi:10.1007/s12576-009-0053-7
Xu, M., He, J., Zhang, C., Xu, J., & Wang, Y. (2019). Strategies for derivation of endothelial lineages from human stem cells. Stem cell research & therapy, 10 (1), 200. Retrieved fromhttps://pubmed.ncbi.nlm.nih.gov/31286997 . doi:10.1186/s13287-019-1274-1
Xu, S., Tao, J., Yang, L., Zhang, E., Boriboun, C., Zhou, J., . . . Qin, G. (2018). E2F1 Suppresses Oxidative Metabolism and Endothelial Differentiation of Bone Marrow Progenitor Cells. Circ Res, 122 (5), 701-711. doi:10.1161/circresaha.117.311814
Yamamoto, K., Nishimura, R., Kato, F., Naito, A., Suda, R., Sekine, A., . . . Tatsumi, K. (2020). Protective role of endothelial progenitor cells stimulated by riociguat in chronic thromboembolic pulmonary hypertension. International journal of cardiology, 299 , 263-270. doi:10.1016/j.ijcard.2019.07.017
Yang, J. X., Pan, Y. Y., Wang, X. X., Qiu, Y. G., & Mao, W. (2018). Endothelial progenitor cells in age-related vascular remodeling.Cell Transplant, 27 (5), 786-795. doi:10.1177/0963689718779345
Yang, J. X., Pan, Y. Y., Zhao, Y. Y., & Wang, X. X. (2013). Endothelial progenitor cell-based therapy for pulmonary arterial hypertension.Cell Transplant, 22 (8), 1325-1336. Retrieved fromhttps://www.ncbi.nlm.nih.gov/pubmed/23295102 . doi:10.3727/096368912X659899
Yang, Y., Lin, H., Shen, H., Wang, B., Lei, G., & Tuan, R. S. (2018). Mesenchymal stem cell-derived extracellular matrix enhances chondrogenic phenotype of and cartilage formation by encapsulated chondrocytes in vitro and in vivo. Acta biomaterialia, 69 , 71-82. Retrieved fromhttps://pubmed.ncbi.nlm.nih.gov/29317369 . doi:10.1016/j.actbio.2017.12.043
Yao, W., Firth, A. L., Sacks, R. S., Ogawa, A., Auger, W. R., Fedullo, P. F., . . . Yuan, J. X. (2009). Identification of putative endothelial progenitor cells (CD34+CD133+Flk-1+) in endarterectomized tissue of patients with chronic thromboembolic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol, 296 (6), L870-878. doi:10.1152/ajplung.90413.2008
Zhang, S., Chuah, S. J., Lai, R. C., Hui, J. H. P., Lim, S. K., & Toh, W. S. (2018). MSC exosomes mediate cartilage repair by enhancing proliferation, attenuating apoptosis and modulating immune reactivity.Biomaterials, 156 , 16-27. Retrieved fromhttps://pubmed.ncbi.nlm.nih.gov/29182933 . doi:10.1016/j.biomaterials.2017.11.028
Zhang, S. J., Zhang, H., Wei, Y. J., Su, W. J., Liao, Z. K., Hou, M., . . . Hu, S. S. (2006). Adult endothelial progenitor cells from human peripheral blood maintain monocyte/macrophage function throughout in vitro culture. Cell research, 16 (6), 577-584. Retrieved fromhttps://pubmed.ncbi.nlm.nih.gov/16775629 .
Zhao, Q., Liu, Z., Wang, Z., Yang, C., Liu, J., & Lu, J. (2007). Effect of prepro-calcitonin gene-related peptide-expressing endothelial progenitor cells on pulmonary hypertension. Ann Thorac Surg, 84 (2), 544-552. doi:10.1016/j.athoracsur.2007.03.067
Zhao, Y. D., Courtman, D. W., Deng, Y., Kugathasan, L., Zhang, Q., & Stewart, D. J. (2005). Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease. Circulation research, 96 (4), 442-450. Retrieved from https://pubmed.ncbi.nlm.nih.gov/15692087 .
Zhou, L., Chen, Z., Vanderslice, P., So, S. P., Ruan, K. H., Willerson, J. T., & Dixon, R. A. (2013). Endothelial-like progenitor cells engineered to produce prostacyclin rescue monocrotaline-induced pulmonary arterial hypertension and provide right ventricle benefits.Circulation, 128 (9), 982-994. Retrieved fromhttps://www.ncbi.nlm.nih.gov/pubmed/23841984 . doi:10.1161/CIRCULATIONAHA.113.003139
Zhu, S., Li, W., Zhou, H., Wei, W., Ambasudhan, R., Lin, T., . . . Ding, S. (2010). Reprogramming of human primary somatic cells by OCT4 and chemical compounds. Cell Stem Cell, 7 (6), 651-655. doi:10.1016/j.stem.2010.11.015